annual EBITDA:
-$151.35M-$123.35M(-440.55%)Summary
- As of today (June 17, 2025), IMNM annual EBITDA is -$151.35 million, with the most recent change of -$123.35 million (-440.55%) on December 31, 2024.
- During the last 3 years, IMNM annual EBITDA has fallen by -$126.91 million (-519.06%).
- IMNM annual EBITDA is now -2007.11% below its all-time high of -$7.18 million, reached on December 31, 2018.
Performance
IMNM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$43.91M+$11.09M(+20.17%)Summary
- As of today (June 17, 2025), IMNM quarterly EBITDA is -$43.91 million, with the most recent change of +$11.09 million (+20.17%) on March 31, 2025.
- Over the past year, IMNM quarterly EBITDA has dropped by -$23.83 million (-118.65%).
- IMNM quarterly EBITDA is now -1662.04% below its all-time high of -$2.49 million, reached on March 31, 2020.
Performance
IMNM quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$175.18M-$23.83M(-15.74%)Summary
- As of today (June 17, 2025), IMNM TTM EBITDA is -$175.18 million, with the most recent change of -$23.83 million (-15.74%) on March 31, 2025.
- Over the past year, IMNM TTM EBITDA has dropped by -$131.42 million (-300.33%).
- IMNM TTM EBITDA is now -6727.05% below its all-time high of -$2.57 million, reached on September 30, 2019.
Performance
IMNM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IMNM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -440.6% | -118.7% | -300.3% |
| 3 y3 years | -519.1% | -281.2% | -443.3% |
| 5 y5 years | -1456.7% | -1662.0% | -2153.1% |
IMNM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -519.1% | at low | -915.7% | +20.2% | -698.7% | at low |
| 5 y | 5-year | -1456.7% | at low | -1662.0% | +20.2% | -2153.1% | at low |
| alltime | all time | -2007.1% | at low | -1662.0% | +20.2% | -6727.1% | at low |
IMNM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$43.91M(-20.2%) | -$175.18M(+15.7%) |
| Dec 2024 | -$151.35M(+440.6%) | -$55.00M(+27.2%) | -$151.35M(+37.7%) |
| Sep 2024 | - | -$43.24M(+31.0%) | -$109.94M(+54.5%) |
| Jun 2024 | - | -$33.02M(+64.4%) | -$71.17M(+62.6%) |
| Mar 2024 | - | -$20.08M(+47.7%) | -$43.76M(+56.3%) |
| Dec 2023 | -$28.00M(-22.8%) | -$13.59M(+204.3%) | -$28.00M(+27.7%) |
| Sep 2023 | - | -$4.47M(-20.5%) | -$21.93M(-15.3%) |
| Jun 2023 | - | -$5.62M(+29.9%) | -$25.89M(-11.0%) |
| Mar 2023 | - | -$4.32M(-42.6%) | -$29.07M(-19.8%) |
| Dec 2022 | -$36.27M | -$7.53M(-10.6%) | -$36.27M(-0.5%) |
| Sep 2022 | - | -$8.42M(-4.4%) | -$36.47M(+2.8%) |
| Jun 2022 | - | -$8.80M(-23.6%) | -$35.49M(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$11.52M(+49.1%) | -$32.25M(+31.9%) |
| Dec 2021 | -$24.45M(+43.4%) | -$7.73M(+3.9%) | -$24.45M(+19.1%) |
| Sep 2021 | - | -$7.44M(+33.6%) | -$20.53M(-3.5%) |
| Jun 2021 | - | -$5.57M(+49.6%) | -$21.28M(+16.5%) |
| Mar 2021 | - | -$3.72M(-2.2%) | -$18.27M(+7.2%) |
| Dec 2020 | -$17.04M(+75.3%) | -$3.81M(-53.5%) | -$17.04M(+6.8%) |
| Sep 2020 | - | -$8.19M(+220.4%) | -$15.96M(+54.4%) |
| Jun 2020 | - | -$2.56M(+2.6%) | -$10.33M(+32.9%) |
| Mar 2020 | - | -$2.49M(-8.3%) | -$7.78M(+47.2%) |
| Dec 2019 | -$9.72M(+35.4%) | -$2.72M(+5.9%) | -$5.28M(+105.9%) |
| Sep 2019 | - | -$2.57M | -$2.57M |
| Dec 2018 | -$7.18M | - | - |
FAQ
- What is Immunome annual EBITDA?
- What is the all time high annual EBITDA for Immunome?
- What is Immunome annual EBITDA year-on-year change?
- What is Immunome quarterly EBITDA?
- What is the all time high quarterly EBITDA for Immunome?
- What is Immunome quarterly EBITDA year-on-year change?
- What is Immunome TTM EBITDA?
- What is the all time high TTM EBITDA for Immunome?
- What is Immunome TTM EBITDA year-on-year change?
What is Immunome annual EBITDA?
The current annual EBITDA of IMNM is -$151.35M
What is the all time high annual EBITDA for Immunome?
Immunome all-time high annual EBITDA is -$7.18M
What is Immunome annual EBITDA year-on-year change?
Over the past year, IMNM annual EBITDA has changed by -$123.35M (-440.55%)
What is Immunome quarterly EBITDA?
The current quarterly EBITDA of IMNM is -$43.91M
What is the all time high quarterly EBITDA for Immunome?
Immunome all-time high quarterly EBITDA is -$2.49M
What is Immunome quarterly EBITDA year-on-year change?
Over the past year, IMNM quarterly EBITDA has changed by -$23.83M (-118.65%)
What is Immunome TTM EBITDA?
The current TTM EBITDA of IMNM is -$175.18M
What is the all time high TTM EBITDA for Immunome?
Immunome all-time high TTM EBITDA is -$2.57M
What is Immunome TTM EBITDA year-on-year change?
Over the past year, IMNM TTM EBITDA has changed by -$131.42M (-300.33%)